George Medicines initiates two Phase III trials of triple combination candidate to treat hypertension George Medicines initiates two Phase III trials of triple combination candidate to treat hypertension Novel proprietary triple low-dose combination pill has been shown to outperform traditional blood...

George Medicines appoints Stefan König as Chief Executive Officer George Medicines appoints Stefan König as Chief Executive Officer Mr König joins to lead late-stage drug development company developing proprietary fixed dose combination therapies for...

George Medicines appoints Stefan König as Chief Executive Officer George Medicines appoints Stefan König as Chief Executive Officer Mr König joins to lead late-stage drug development company developing proprietary fixed dose combination therapies for...